Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

April 2018 - FRMC

Department

Conference Insider
05/07/2018
A featured poster session at the Society of Gynecologic Oncology’s (SGO) 2018 Annual Meeting detailed the results of a study comparing the efficacy and tolerability of PARP inhibitors as maintenance treatment in BRCA-mutated...
A featured poster session at the Society of Gynecologic Oncology’s (SGO) 2018 Annual Meeting detailed the results of a study comparing the efficacy and tolerability of PARP inhibitors as maintenance treatment in BRCA-mutated...
A featured poster session at the...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
Joyce F Liu, MD, MPH, recently discussed the current and future role of PARP inhibitors for the treatment of ovarian cancer at the Society of Gynecologic Oncology’s 2018 Annual Meeting.
Joyce F Liu, MD, MPH, recently discussed the current and future role of PARP inhibitors for the treatment of ovarian cancer at the Society of Gynecologic Oncology’s 2018 Annual Meeting.
Joyce F Liu, MD, MPH, recently...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
The American Society of Clinical Oncology’s (ASCO) Patient-Centered Oncology Payment (PCOP) model helps achieve costs savings in ovarian cancer when hospitalizations are reduced during the active treatment period, according to a study...
The American Society of Clinical Oncology’s (ASCO) Patient-Centered Oncology Payment (PCOP) model helps achieve costs savings in ovarian cancer when hospitalizations are reduced during the active treatment period, according to a study...
The American Society of Clinical...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
Recent research presented at the ACC 2018 Scientific Session found that urgent or emergent transcatheter aortic valve replacement (TAVR) has acceptable outcomes when compared with elective TAVR. 
Recent research presented at the ACC 2018 Scientific Session found that urgent or emergent transcatheter aortic valve replacement (TAVR) has acceptable outcomes when compared with elective TAVR. 
Recent research presented at the...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
A recent clinical trial found that while reducing copayments for myocardial infarction (MI) patients taking P2Y12 receptor inhibitors improved adherence, it did not impact clinical outcomes after 1 year.
A recent clinical trial found that while reducing copayments for myocardial infarction (MI) patients taking P2Y12 receptor inhibitors improved adherence, it did not impact clinical outcomes after 1 year.
A recent clinical trial found...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
New data released at the 2018 ACC Scientific Session confirmed that use of SGLT-2 inhibitors among patients with type-2 diabetes significantly decreases risk for cardiovascular death.
New data released at the 2018 ACC Scientific Session confirmed that use of SGLT-2 inhibitors among patients with type-2 diabetes significantly decreases risk for cardiovascular death.
New data released at the 2018...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
David Calabrese, RPh, MHP, Chief Pharmacy Officer at OptumRx, discussed how payers and PBMs can mitigate the risk and impact of the current opioid crisis in the United States, during his session at the PBMI 2018 National Conference.
David Calabrese, RPh, MHP, Chief Pharmacy Officer at OptumRx, discussed how payers and PBMs can mitigate the risk and impact of the current opioid crisis in the United States, during his session at the PBMI 2018 National Conference.
David Calabrese, RPh, MHP, Chief...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
Recently at the PBMI 2018 Annual Meeting, George Hill, managing director at RBC Capital Markets, recapped some recent marketplace changes and gave his outlook on how the PBM landscape is trending.
Recently at the PBMI 2018 Annual Meeting, George Hill, managing director at RBC Capital Markets, recapped some recent marketplace changes and gave his outlook on how the PBM landscape is trending.
Recently at the PBMI 2018 Annual...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
During the keynote presentation at PBMI, Adam Fein, PhD, discussed the current place of PBMs in the market and how he sees this changing in the near future.
During the keynote presentation at PBMI, Adam Fein, PhD, discussed the current place of PBMs in the market and how he sees this changing in the near future.
During the keynote presentation...
05/07/2018
First Report Managed Care
Conference Insider
05/07/2018
During PBMI 2018, Steve Pearson, MD, explained how payers can improve access to high cost drugs without sacrificing affordability.
During PBMI 2018, Steve Pearson, MD, explained how payers can improve access to high cost drugs without sacrificing affordability.
During PBMI 2018, Steve Pearson,...
05/07/2018
First Report Managed Care

Advertisement

Advertisement

Advertisement